EN
HI
Glaxosmithkline Pharmaceuticals Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
60144.00
Market Cap
42131.28 CR
LTQ@LTP
1@2487.00
ATP
2512.96
Var Margin
16.56 %
Circuit Range
2015.4-3023
Delivery %
53.36 %
Value
15.11 CR
ASM/GSM
No
Market Lot
1
Summary
At 10 Mar, 2026 | 15:56, Glaxosmithkline Pharmaceuticals share price stands at ₹2487, showing a 32.20% -1.28 for the day. The stock’s intraday movement has stayed between ₹2473.00 and ₹2554.00, while on a 52-week basis it has fluctuated from ₹2220.30 to ₹3515.70.
In terms of trading activity, Glaxosmithkline Pharmaceuticals has recorded a volume of 60144 shares, with a market capitalisation of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹251296, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,248700. The stock operates within a circuit range of ₹2015.4-3023, with a Value of ₹15.11 CR. The Delivery Percentage for the day is 53.36%. Additionally, Glaxosmithkline Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Glaxosmithkline Pharmaceuticals Fundamentals
View MoreP/E Ratio
41.84
P/B Ratio
21.32
Div. Yield
2.14
Sector P/E
60.42
Sector P/B
2.64
Sec. Div. Yield
0.58
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2499.97
Resistance
First Resistance
2549.14
Second Resistance
2579.07
Third Resistance
2628.24
Support
First Support
2470.04
Second Support
2420.87
Third Support
2390.94
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
Glaxosmithkline Pharmaceuticals News
With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline Pharmaceuticals
Aug 23 2021 14:30:22
With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline Pharmaceuticals
Aug 23 2021 14:15:31
Read More
About Glaxosmithkline Pharmaceuticals
NSE : 1153
BSE : 500660
ISIN : INE159A01016
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
Glaxosmithkline Pharmaceuticals Similar Stocks
Alkem Laboratories Ltd.
5616.50
156.50 (2.87%)
Biocon Ltd.
395.80
6.10 (1.57%)
Glenmark Pharmaceuticals Ltd.
2225.80
108.20 (5.11%)
Abbott India Ltd.
26810.00
-375.00 (1.38%)
Laurus Labs Ltd.
1038.00
17.00 (1.67%)
Ipca Laboratories Ltd.
1491.20
-11.40 (0.76%)
Ajanta Pharma Ltd.
2999.90
63.50 (2.16%)
Anthem Biosciences Ltd.
670.15
10.00 (1.51%)
Narayana Hrudayalaya Ltd.
1750.50
-7.70 (0.44%)
Aster DM Healthcare Ltd.
665.50
7.20 (1.09%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2487 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 41.84. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 21.32. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 60.42 & 2.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 42131.28 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3515.70 & 2220.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
